期刊
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
卷 279, 期 4, 页码 533-537出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00404-008-0774-5
关键词
Rhesus D; RHD; MALDI-TOF; Non-invasive; Saber assay
资金
- European Commission for the Special Non-invasive Advances in Fetal and Neonatal Evaluation (SAFE) Network of Excellence [LSHB-CT-2004-503243]
- Swiss National Science Foundation [SNSF 3200B0-107697/1]
To examine the potential high throughput capability and efficiency of an automated DNA extraction system in combination with mass spectrometry for the non-invasive determination of the foetal Rhesus D status. A total of 178 maternal plasma samples from RHD-negative pregnant women were examined, from which DNA was extracted using the automated Roche MagNA Pure (TM) system. Presence of the foetal RHD gene was detected by PCR for RHD exon 7 and subsequent analysis using the Sequenom MassArray (TM) mass spectrometric system. We determined that as little as 15 pg of RHD-positive genomic DNA could be detected in a background of 585 pg of RHD-negative genomic DNA. The analysis of the clinical samples yielded a sensitivity and specificity of 96.1 and 96.1%, respectively. Our study indicated that automated DNA extraction in combination with mass spectrometry permits the determination of foetal Rhesus D genotype with an accuracy comparable to the current approaches using real-time PCR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据